Emergence of Generative Language

December 2, 2016 updated by: Alice Shillingsburg, Emory University

Instructional Programming to Promote the Emergence of Generative Language in Children With Autism Spectrum Disorder

The purpose of this study is to investigate the effects of several applied behavior teaching procedures on the use of multi-word utterances by children with autism.

Study Overview

Study Type

Interventional

Enrollment (Actual)

9

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

2 years to 4 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diagnosis of Autism Spectrum Disorder (ASD)
  • Provide a diagnostic report confirming a diagnosis of ASD and/or obtain a total raw score of 15 or greater on the Social Questionnaire Lifetime Form (SCQ)
  • Speaks primarily in one word utterances
  • English as their primary language
  • Follows simple 1-step instructions
  • Transportation/availability to attend 3, 1-hour sessions each week for 12 weeks

Exclusion Criteria:

  • Children with significant problem behavior that interferes with structured intervention

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: One Baseline Session
Designated for participants #1 and #2. Participants complete 1 Baseline Session followed immediately by 12 weeks of standard treatment. Standard treatment will require the participant to attend clinic-based treatment sessions for 1 hour per day, 3 days per week, for 12 weeks. Standard treatment will consist of 3 components: mand training, matrix training, and stimulus equivalence training.
The mand training component of treatment will consist of behavioral principles designed to increase the participant's Mean Length of Utterances (MLU) when manding.
The matrix training component of treatment will consist of behavioral principles designed to teach labeling of noun-verb and color-shape combinations using matrix training.
The stimulus equivalence training component of treatment is designed to examine the emergence of untrained skills following the training of relational skills.
Experimental: Two Baseline Sessions
Designated for participants #3 and #4. Participants complete a Baseline Session followed by a 12 week wait period before repeating a Baseline Session followed immediately by 12 weeks of standard treatment. Standard treatment will require the participant to attend clinic-based treatment sessions for 1 hour per day, 3 days per week, for 12 weeks. Standard treatment will consist of 3 components: mand training, matrix training, and stimulus equivalence training.
The mand training component of treatment will consist of behavioral principles designed to increase the participant's Mean Length of Utterances (MLU) when manding.
The matrix training component of treatment will consist of behavioral principles designed to teach labeling of noun-verb and color-shape combinations using matrix training.
The stimulus equivalence training component of treatment is designed to examine the emergence of untrained skills following the training of relational skills.
Experimental: Three Baseline Sessions
Designated for participants #5 and #6. Participants complete a Baseline Session followed by two repetitions of the Baseline Session (each 12 weeks apart) and 12 weeks of standard treatment immediately following the third session. Standard treatment will require the participant to attend clinic-based treatment sessions for 1 hour per day, 3 days per week, for 12 weeks. Standard treatment will consist of 3 components: mand training, matrix training, and stimulus equivalence training.
The mand training component of treatment will consist of behavioral principles designed to increase the participant's Mean Length of Utterances (MLU) when manding.
The matrix training component of treatment will consist of behavioral principles designed to teach labeling of noun-verb and color-shape combinations using matrix training.
The stimulus equivalence training component of treatment is designed to examine the emergence of untrained skills following the training of relational skills.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Mean Length of Utterances (MLU) during manding
Time Frame: Baseline (Up to 24 Weeks), End of Standard Treatment (Up to 36 weeks)
The mean length of utterances (MLU) during manding will be evaluated in a 10 minute probe. The goal of intervention is to increase of MLU to an average of 3 words per mand.
Baseline (Up to 24 Weeks), End of Standard Treatment (Up to 36 weeks)
Acquisition of noun-verb and color-shape combinations during tacting
Time Frame: Baseline (Up to 24 Weeks), End of Standard Treatment (Up to 36 weeks)
The goal of intervention is mastery of 80% of evaluated noun-verb and color-shape targets.
Baseline (Up to 24 Weeks), End of Standard Treatment (Up to 36 weeks)
Emergence of intraverbal responses
Time Frame: Baseline (Up to 24 Weeks), End of Standard Treatment (Up to 36 weeks)
The goal of intervention is the mastery of 80% of evaluated intraverbal responses (2 for each target, 18 total).
Baseline (Up to 24 Weeks), End of Standard Treatment (Up to 36 weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Macarthur Bates-Communicative Development Inventory (CDI) Score
Time Frame: Baseline (Up to 24 Weeks), End of Standard Treatment (Up to 36 weeks)
The Macarthur Bates-Communicative Development Inventory (CDI) is completed by a parent/caregiver and evaluates current word use . A higher score indicates the use of more words.
Baseline (Up to 24 Weeks), End of Standard Treatment (Up to 36 weeks)
Observe overall improvements in pragmatic language within social/play interactions with parents/caregivers, as measured on the Direct Observation of Spoken Language (DOSL).
Time Frame: Baseline (Up to 24 Weeks), End of Standard Treatment (Up to 36 weeks)
A goal of the intervention is to observe an increase in spontaneous mands, an increase in spontaneous tacts, as well as an increase in intraverbal responses.
Baseline (Up to 24 Weeks), End of Standard Treatment (Up to 36 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Alice Shillingsburg, Emory University Assistant Professor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2015

Primary Completion (Actual)

November 1, 2016

Study Completion (Actual)

November 1, 2016

Study Registration Dates

First Submitted

September 17, 2015

First Submitted That Met QC Criteria

September 17, 2015

First Posted (Estimate)

September 21, 2015

Study Record Updates

Last Update Posted (Estimate)

December 5, 2016

Last Update Submitted That Met QC Criteria

December 2, 2016

Last Verified

December 1, 2016

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • IRB00080641

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Autism Spectrum Disorder

Clinical Trials on Mand Training

3
Subscribe